1.
Blood-pressure-related disease is a global health priority
by MacMahon, Stephen
American journal of hypertension, 2008, Vol.371 (9623), p.1480-1482
2.
Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients
by Okin, Peter M.
American journal of hypertension, 2010-07, Vol.23 (7), p.786-793
3.
Blood-pressure-related disease is a global health priority
by MacMahon, Stephen
American journal of hypertension, 2008-08, Vol.21 (8), p.843
4.
Blood-Pressure-Related Disease Is a Global Health Priority
by MacMahon, Stephen
American journal of hypertension, 2008-08, Vol.21 (8), p.843-844
5.
Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study
by Okin, Peter M.
American journal of hypertension, 2008-03, Vol.21 (3), p.273-279
6.
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study
by Kjeldsen, Sverre E
American journal of hypertension, 2000, Vol.13 (8), p.899-906
7.
The STOP-hypertension-2 study
by Lindholm, Lars H
American journal of hypertension, 2000, Vol.13 (4), p.325A-332A
8.
OR-60: Long-term metabolic effects of a candesartan vs hydrochlorothiazide based antihypertensive treatment: Results of the alpine study
by Lindholm, Lars H.
American journal of hypertension, 2003-05, Vol.16 (S1), p.27A-27A
9.
Serum Uric Acid Is Associated With New-Onset Diabetes in Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Study
by Wiik, Benedicte P.
American journal of hypertension, 2010-08, Vol.23 (8), p.845-851
10.
P-329: 1999 WHO/ISH risk stratification for hypertension applied to the 1999 MONICA-sample from Northern Sweden
by Persson, Mats R.
American journal of hypertension, 2001-04, Vol.14 (S1), p.138A-139A
11.
O-30: Predictors of cardiovascular events in 9,194 hypertensive patients with left ventricular hypertrophy. The LIFE study
by Kjeldsen, Sverre E.
American journal of hypertension, 2001-04, Vol.14 (S1), p.14A-14A
12.
Long-term metabolic effects of a candesartan vs hydrochlorothiazide based antihypertensive treatment: results of the alpine study
by Lindholm, Lars H
American journal of hypertension, 2003-05, Vol.16 (5), p.A27-A27
13.
1999 WHO/ISH risk stratification for hypertension applied to the 1999 MONICA-sample from Northern Sweden
by Persson, Mats R
American journal of hypertension, 2001-04, Vol.14 (4), p.A138-A139
14.
Predictors of cardiovascular events in 9,194 hypertensive patients with left ventricular hypertrophy. The LIFE study
by Kjeldsen, Sverre E
American journal of hypertension, 2001-04, Vol.14 (4), p.A14-A14
15.
The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study
by Dahlöf, Björn
American journal of hypertension, 1997-07, Vol.10 (7), p.705-713
16.
Albuminuria predicts cardiovascular outcome with losartan versus atenolol in patients with diabetes, hypertension and left ventricular hypertrophy. A life diabetes substudy
by Ibsen, Hans
American journal of hypertension, 2004, Vol.17 (5), p.S2-S2
Filter electronic articles 16 Hits
Remove Filters
- Journal Title
- American Journal Of Hypertension
- The Lancet (1)